Molecular Medicine PhD Program

This PhD Program trains students to use advances in basic sciences to solve problems relevant to human disease, and to use insights from human disease processes to solve fundamental biological problems.

This is unpublished

about 

 

Contact 

Co-director:

Conrad LilesW. Conrad Liles
Professor of Medicine
Associate Chair for Research
Co-Director, M3D

Phone: (206) 543-3293
Email: wcliles@uw.edu

Dubbed “M3D”, Molecular Medicine & Mechanisms of Disease is a direct entry Ph.D. graduate program for basic science investigation of disease mechanisms. 

M3D trains graduate students to use advances in basic sciences to solve problems relevant to human disease and to use insights from human disease processes to solve fundamental biological problems. 

Collaborative effort

The M3D PhD Program is a collaborative effort among the Departments of Medicine, Pathology and Pediatrics. Students may carry out PhD research with any qualified faculty member in one of those participating departments. Qualified faculty from other departments may train M3D PhD students, provided that the faculty member commits to support the student while in training.

Seminar Series

2023 Seminar Series: Challenges in cancer immunotherapy

April 5, 2023

12:30 pm, Pelton Auditorium

Aude Chapuis

Challenges in Immunotherapy:
Fine-tuning T cell receptor-based therapies

Aude G. Chapuis, MD
Associate Professor, Medical Oncology

April 12, 2023

12:30 pm, Pelton Auditorium

Nora Disis

A New Era For Cancer Vaccines

Nora Disis, MD
Professor, Medical Oncology

April 19, 2023

1:00 pm, Sze D1-084

Stan Riddell

Engineering T cells with synthetic receptors for cancer therapy

Stan Riddell, MD
Professor, Medical Oncology

April 26, 2023

12:30 pm, Pelton Auditorium

Tina Albertson

Immunotherapy drug trials:
From academics to industry

Tina Albertson, MD, PhD
Chief Medical Officer, Lyell Immunopharma


May 3, 2023

12:30 pm, Pelton Auditorium

Damian Green

Challenges and successes targeting multiple myeloma with radiolabeled antibodies and adoptive immunotherapy

Damian Green, MD
Associate Professor, Medical Oncology